Zhi‐Ling Yu

9.0k total citations · 3 hit papers
234 papers, 7.0k citations indexed

About

Zhi‐Ling Yu is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Zhi‐Ling Yu has authored 234 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Molecular Biology, 53 papers in Pharmacology and 38 papers in Complementary and alternative medicine. Recurrent topics in Zhi‐Ling Yu's work include Natural product bioactivities and synthesis (31 papers), Traditional Chinese Medicine Analysis (22 papers) and Pharmacological Effects of Natural Compounds (20 papers). Zhi‐Ling Yu is often cited by papers focused on Natural product bioactivities and synthesis (31 papers), Traditional Chinese Medicine Analysis (22 papers) and Pharmacological Effects of Natural Compounds (20 papers). Zhi‐Ling Yu collaborates with scholars based in Hong Kong, China and United States. Zhi‐Ling Yu's co-authors include Xiu‐Qiong Fu, Anfernee Kai‐Wing Tse, Hiu Yee Kwan, Tao Su, Si-Yuan Pan, Huihui Cao, Kam‐Ming Ko, Wang‐Fun Fong, Brian Chi‐Yan Cheng and Peili Zhu and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Zhi‐Ling Yu

227 papers receiving 6.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics

2013 483 citations Zhi‐Ling Yu et al. profile →
Historical Perspective of Traditional Indigenous Medical Practices: The Current Renaissance and Conservation of Herbal Resources

2014 347 citations Zhi‐Ling Yu et al. profile →
Tea and tea drinking: China’s outstanding contributions to the mankind

2022 169 citations Zhi‐Ling Yu, Chun Liang et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Zhi‐Ling Yu	3.4k	1.1k	1.1k	895	782	234	7.0k
Gholamreza Karimi	3.0k 0.9×	1.3k 1.2×	886 0.8×	744 0.8×	928 1.2×	294	8.5k
Sarwat Sultana	2.6k 0.8×	1.3k 1.2×	1.6k 1.5×	909 1.0×	695 0.9×	194	7.5k
Jae‐Young Um	3.5k 1.0×	824 0.7×	842 0.8×	867 1.0×	759 1.0×	263	7.5k
Jinyong Peng	4.6k 1.3×	1.1k 1.0×	1.4k 1.3×	721 0.8×	732 0.9×	220	9.3k
Seong‐Gyu Ko	2.6k 0.8×	745 0.7×	797 0.7×	938 1.0×	901 1.2×	306	5.7k
Youn‐Chul Kim	4.0k 1.1×	1.5k 1.3×	1.3k 1.3×	1.1k 1.2×	1.4k 1.8×	270	7.7k
Won Keun Oh	4.5k 1.3×	1.3k 1.1×	1.1k 1.0×	664 0.7×	1.2k 1.5×	268	8.0k
Rakesh Maurya	3.1k 0.9×	1.4k 1.2×	713 0.7×	1.1k 1.3×	667 0.9×	226	6.6k
Boyang Yu	5.2k 1.5×	1.3k 1.2×	1.2k 1.1×	1.5k 1.6×	922 1.2×	489	9.5k
Sei‐Ryang Oh	3.4k 1.0×	1.6k 1.4×	823 0.8×	773 0.9×	977 1.2×	290	6.8k

Countries citing papers authored by Zhi‐Ling Yu

Since Specialization

Citations

This map shows the geographic impact of Zhi‐Ling Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Ling Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Ling Yu more than expected).

Fields of papers citing papers by Zhi‐Ling Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi‐Ling Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Ling Yu. The network helps show where Zhi‐Ling Yu may publish in the future.

Co-authorship network of co-authors of Zhi‐Ling Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi‐Ling Yu. A scholar is included among the top collaborators of Zhi‐Ling Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi‐Ling Yu. Zhi‐Ling Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Shuyan, et al.. (2025). Study on vapor–liquid equilibrium for the separation of ethyl acetate and isopropanol azeotrope using phosphonium-based ionic liquids. Fuel. 386. 134225–134225.

Li, Xia, Shuyan Liu, Chenglong Sun, et al.. (2025). Experimental and mechanistic study on liquid–liquid equilibrium for the separation of cyclohexane and ethyl acetate using imidazolium ionic liquids. Fuel. 392. 134860–134860.

Wang, Xiaoqi, Jia‐Ying Wu, Yingjie Chen, et al.. (2025). A tri-compound formula comprising Ginsenoside Rg1, tetrandrine and icariin alleviates atopic dermatitis symptoms in a mouse model. Phytomedicine. 141. 156737–156737. 2 indexed citations

Wang, Jingwen, Jingyang Zhang, Zhi‐Ling Yu, Sookja Kim Chung, & Baojun Xu. (2024). The roles of dietary polyphenols at crosstalk between type 2 diabetes and Alzheimer's disease in ameliorating oxidative stress and mitochondrial dysfunction via PI3K/Akt signaling pathways. Ageing Research Reviews. 99. 102416–102416. 21 indexed citations

Chen, Wei, Chen Wang, Yuling Liang, et al.. (2024). Identification of sedative-hypnotic compounds shared by five medicinal Polyporales mushrooms using UPLC-Q-TOF-MS/MS-based untargeted metabolomics. Phytomedicine. 128. 155355–155355. 4 indexed citations

Chen, Jiali, Yuhang Xiao, Kun Wang, et al.. (2024). Sea bass (Lateolabrax maculatus) exerts anti‐ulcerative colitis effects through gut microbiota modulation. SHILAP Revista de lepidopterología. 5(2). 522–534. 6 indexed citations

Eglitis, R. I., et al.. (2024). Chiisanoside from the Leaves of Acanthopanax sessiliflorus Can Resist Cisplatin-Induced Ototoxicity by Maintaining Cytoskeletal Homeostasis and Inhibiting Ferroptosis. Journal of Agricultural and Food Chemistry. 72(46). 25720–25742. 3 indexed citations

Zhu, Ke‐Wei, Zhe Yang, Guili Liu, et al.. (2024). Symptoms can predict COVID-19 pneumonia in patients infected with SARS-CoV-2 Omicron variants. Scientific Reports. 14(1). 30037–30037.

Khan, Muhammad Ajmal, et al.. (2023). An essential Noc3p dimerization cycle mediates ORC double-hexamer formation in replication licensing. Life Science Alliance. 6(3). e202201594–e202201594. 1 indexed citations

10.

Liu, Yuchen, Gang Wei, Fang‐Xin Wang, et al.. (2023). Design and Synthesis of Novel Indole Ethylamine Derivatives as a Lipid Metabolism Regulator Targeting PPARα/CPT1 in AML12 Cells. Molecules. 29(1). 12–12. 4 indexed citations

11.

Hu, Jinhui, Li Chen, Yunfei Hu, et al.. (2023). Design, Synthesis and Antitumor Activity of Novel Selenium-Containing Tepotinib Derivatives as Dual Inhibitors of c-Met and TrxR. Molecules. 28(3). 1304–1304. 9 indexed citations

12.

Luo, Jinhai, et al.. (2023). A critical review on intestinal mucosal barrier protection effects of dietary polysaccharides. Food & Function. 15(2). 481–492. 23 indexed citations

13.

Qiu, Jiannan, Lin Chen, Ling Zhang, et al.. (2023). Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy. Phytomedicine. 121. 155111–155111. 41 indexed citations

14.

Huang, Shiying, Benjamin Chun‐Kit Tong, Aston Jiaxi Wu, et al.. (2023). Targeting calcium signaling by inositol trisphosphate receptors: A novel mechanism for the anti-asthmatic effects of Houttuynia cordata. Biomedicine & Pharmacotherapy. 164. 114935–114935. 7 indexed citations

15.

Zhu, Linwensi, Qinchao Ding, Tiantian Xu, et al.. (2022). Cimifugin Ameliorates Lipotoxicity‐Induced Hepatocyte Damage and Steatosis through TLR4/p38 MAPK‐ and SIRT1‐Involved Pathways. Oxidative Medicine and Cellular Longevity. 2022(1). 4557532–4557532. 22 indexed citations

16.

Zhang, Hailei, Huan Zhong, Xufeng Wang, et al.. (2021). Use of NAD tagSeq II to identify growth phase-dependent alterations in E. coli RNA NAD ⁺ capping. Proceedings of the National Academy of Sciences. 118(14). 18 indexed citations

17.

Kwan, Hiu Yee, Jiahui Wu, Tao Su, et al.. (2017). Schisandrin B regulates lipid metabolism in subcutaneous adipocytes. Scientific Reports. 7(1). 10266–10266. 17 indexed citations

18.

Cao, Hui, et al.. (2017). [Status and suggestions for adjuvant standard for Chinese materia medica processing in China].. PubMed. 42(7). 1401–1406. 1 indexed citations

19.

Su, Tao, Brian Chi‐Yan Cheng, Xiu‐Qiong Fu, et al.. (2016). Comparison of the toxicities, bioactivities and chemical profiles of raw and processed Xanthii Fructus. BMC Complementary and Alternative Medicine. 16(1). 17 indexed citations

20.

Wu, Jian, Chi-On Chan, Daniel Kam‐Wah Mok, et al.. (2014). Petroleum ether extractive of the hips of Rosa multiflora ameliorates collagen-induced arthritis in rats. Journal of Ethnopharmacology. 157. 45–54. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact